GlassScriptPhysician profile
Kimberly Ann Smith
NPI 1780831958
$2,135.58
in general payments reported to CMS, 2019-2025
18 companies · $20.15 in 2025
The $20.15 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.39 · 2020: $10.12 · 2021: $80.27 · 2022: $211 · 2023: $1,657 · 2024: $133 · 2025: $20.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,218 · Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,217.98 |
| Food and Beverage | $592.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,651.92 | 2020-2023 | Portfolio |
| Stryker Corporation | $80.27 | 2021 | |
| Smith+Nephew, INC. | $77.93 | 2022-2025 | Grafix Pl, Stravix |
| Nevro Corp. | $52.23 | 2022-2024 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.72 | 2022 | |
| Curonix LLC | $37.29 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Integra Lifesciences Corporation | $25.47 | 2022 | |
| Paratek Pharmaceuticals, INC. | $22.18 | 2024 | Nuzyra |
| Depuy Synthes Sales INC. | $21.28 | 2024 | |
| Abbvie INC. | $19.64 | 2022 | |
| Bioventus LLC | $19.38 | 2022 | |
| Averitas Pharma INC. | $14.32 | 2023 | Qutenza |
| Treace Medical Concepts, INC. | $12.94 | 2022 | |
| Kerecis Limited | $12.46 | 2022 | |
| Orthofix Medical, INC. | $12.42 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $12.39 | 2019 | |
| Celularity INC. | $12.00 | 2019 | |
| Lifenet Health | $6.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.